Role of transforming growth factor-β1 in the process of fibrosis of denervated skeletal muscle

Abstract

In order to investigate the biological function of transforming growth factor-β1 (TGF-β1) during fibrosis in denervated skeletal muscle, we recruited sciatic nerve injury model of SD rats in which denervated gastrocnemius was isolated for analysis. At different time points after operation, denervated muscle was examined by several methods. Masson trichrome staining showed morphological changes of denervated skeletal muscle. Quantitative RT-PCR detected the rapid increase of TGF-β1 expression at mRNA level after nerve injury. It was found that a peak of TGF-β1 mRNA expression appeared one week post-operation. The expression of collagen I (COL I) mRNA was up-regulated in the nerve injury model as well, and reached highest level two weeks post-injury. Immunoblot revealed similar expression pattern of TGF-β1 and COL I in denervated muscles at protein level. In addition, we found that the area of the gastrocnemius muscle fiber was decreased gradually along with increased interstitital fibrosis. Interestingly, this pathological change could be prevented, at least partly, by local injection of TGF-β1 antibodies, which could be contributed to the reduced production of COL I by inhibiting function of TGF-β1. Taken together, in this study, we demonstrated that the expression of TGF-β1 was increased significantly in denervated skeletal muscle, which might play a crucial role during muscle fibrosis after nerve transection.

Keywords

transforming growth factor β1 / denervation / muscle fibrosis

References

[1] LiY., CumminsJ., HuardJ.. Muscle injury and repair. Curr Opin Orthop, 2001, 12(5): 409-415

[2] GrefteS., Kuijpers-JagtmanA.M., TorensmaR., et al.. Skeletal muscle development and regeneration. Stem Cells Dev, 2007, 16(5): 857-868

[3] LiuY.. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int, 2006, 69(2): 213-217

[4] GressnerA.M., WeiskirchenR.. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med, 2006, 10(1): 76-99

[5] KhanR., SheppardR.. Fibrosis in heart disease: understanding the role of transforming growth factor beta in cardiomyopathy, valvular disease and arrhythmia. Immunology, 2006, 118(1): 10-24

[6] MauvielA.. Transforming growth factor-beta: a key mediator of fibrosis. Methods Mol Med, 2005, 117: 69-80

[7] PiaB., Di ClaudiaB., MarinaM., et al.. Transforming growth factor-β1 and fibrosis in congenital muscular dystrophies. Neuromuscul disord, 1999, 9(1): 28-33

[8] ClancyR.M., BackerC.B., YinX.M., et al.. Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-α and TGF-β1 to the pathogenesis of autoimmune-associated congenital heart. J Immunol, 2003, 171(6): 3253-3261

[9] ChenY.W., NagarajuK., BakayM., et al.. Early onset of inflammation and later involvement of TGFβ in Duchenne muscular dystrophy. Neurology, 2005, 65(6): 826-834

[10] ZanottiaS., SarediaS., RuggieriaA., et al.. Altered extracellular matrix transcript expression and protein modulation in primary Duchenne muscular dystrophy myotubes. Matrix Biology, 2007, 26(8): 615-624

[11] HolzerU., RieckM., BucknerJ.H.. Lineage and signal strength determine the inhibitory effect of transforming growth factor beta 1 (TGF-beta 1) on human antigen-specific Th1 and Th2 memory cells. J Autoimmun, 2006, 26(4): 241-251

[12] ChaeH.J., HaM.S., YunD.H., et al.. Mechanism of cyclosporine-induced overgrowth in gingiva. J Dent Res, 2006, 85(6): 515-519

[13] LiY., FosterW., DeasyB.M., et al.. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol, 2004, 164(3): 1007-1019

[14] LiuQ., MaoH., NieJ., et al.. Transforming growth factor beta 1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells. Perit Dial Int, 2008, 28(3): S88-95

[15] LanH.Y.. Smad7 as a therapeutic agent for chronic kidney diseases. Front Biosci, 2008, 13: 4984-4992

[16] AskK., MartinG.E., KolbM., et al.. Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls. Proc Am Thorac Soc, 2006, 3(4): 389-393

[17] Schultze-MosgauS., WehrhanF., RödelF., et al.. Anti-TGFbeta1 antibody for modulation of expression of endogenous transforming growth factor beta 1 to prevent fibrosis after plastic surgery in rats. Br J Oral Maxillofac Surg, 2004, 42(2): 112-119

[18] ChenK., WeiY., SharpG.C., et al.. Inhibition of TGFbeta1 by anti-TGFbeta1 antibody or lisinopril reduces thyroid fibrosis in granulomatous experimental autoimmune thyroiditis. J Immunol, 2002, 169(11): 6530-6538

[19] WenX., LiY., HuK., et al.. Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells. Am J Pathol, 2005, 167(4): 947-957

[20] ZhangD., LiuM., DingF., et al.. Expression of myostatin RNA transcript and protein in gastrocnemius muscle of rats after sciatic nerve resection. J Muscle Res Cell Motil, 2006, 27(1): 37-44

[21] ShaoC., LiuM., WuX., et al.. Time-dependent expression of myostatin RNA transcript and protein in gastrocnemius muscle of mice after sciatic nerve resection. Microsurgery, 2007, 27(5): 487-93

[22] GosselinL.E., WilliamsJ.E., DeeringM., et al.. Localization and early time course of TGF-beta1 mRNA expression in dystrophic muscle. Muscle Nerve, 2004, 30(5): 645-653

[23] AndreettaF., BernasconiP., BaggiF., et al.. Immunomodu lation of TGF-beta 1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: implications for antifibrotic therapy. J Neuroimmunol, 2006, 175(1–2): 77-86

[24] GoetschS.C., HawkeT.J., GallardoT.D., et al.. Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiol Genomics, 2003, 14(3): 261-271

[25] SmithC.A., StauberF., WatersC., et al.. Transforming growth factor-beta following skeletal muscle strain injury in rats. J Appl Physiol, 2007, 102(2): 755-761

[26] FosterW., LiY., UsasA., et al.. Gamma interferon as an antifibrosis agent in skeletal muscle. J Orthop Res, 2003, 21(5): 798-804

[27] ChanY.S., LiY., FosterW., et al.. Antifibrotic effects of suram in injured skeletal muscle after laceration. J Appl Physiol, 2003, 95(2): 771-780

[28] Schultze-MosgauS., BlaeseM.A., GrabenbauerG., et al.. Smad-3 and Smad-7 expression following anti-transfo rming growth factor beta 1 (TGFbeta1)-treatment in irradiated rat tissue. Radiother Oncol, 2004, 70(3): 249-259

[29] ArrudaE.M., MundyK., CalveS., et al.. Denervation does not change the ratio of collagen I and collagen III mRNA in the extracellular matrix of muscle. Am J Physiol Regul Integr Comp Physiol, 2007, 292(2): R983-987

[30] LehtoM.U., JarvinenM.J.. Muscle injuries, their healing process and treatment. Ann Chir Gynaecol, 1991, 80(2): 102-108

[31] WangW., PanH., MurrayK., et al.. Matrix metalloproteinase-1 promotes muscle cell migration and differentiation. Am J Pathol, 2009, 174(2): 541-549

[32] DowD.E., DennisR.D., FaulknerJ.A.. Electrical stimulation attenuates denervation and age-related atrophy in extensor digitorum longus muscles of old rats. J Gerontol A Biol Sci Med Sci, 2005, 60(4): 416-424

[33] KumarR., KatochS.S., SharmaS.. Beta-adrenoceptor agonist treatment reverses denervation atrophy with augmentation of collagen proliferation in denervated mice gastrocnemius muscle. Indian J Exp Biol, 2006, 44(5): 371-376

[34] KumarR., SharmaS.. Remodeling of extracellular matrix protein, collagen by beta-adrenoceptor stimulation and denervation in mouse gastrocnemius muscle. J Physiol Sci, 2006, 56(1): 87-94